Chronic hypercapnic respiratory failure and non-invasive ventilation in people with chronic obstructive pulmonary disease.
Umur HatipoğluLoutfi Sami AboussouanPublished in: BMJ medicine (2022)
Chronic obstructive pulmonary disease (COPD) should no longer be seen as a condition for which little can be done. Novel pharmacotherapeutic interventions, surgical and procedural advances, and respiratory assist devices have provided numerous ways to help patients with COPD and treatable traits. For nearly 30 years, non-invasive ventilation, the application of positive pressure through a mask interface placed outside of the airway, has been the cornerstone for treatment of acute hypercapnic respiratory failure due to COPD exacerbation. Clinical trials indicate that this intervention could benefit patients with COPD and chronic hypercapnic respiratory failure in a stable state. This narrative review aims to provide the necessary background for internists to consider this therapeutic option for their COPD patients. We discuss the mechanism of action and implementation, and provide a glimpse into the future of this promising intervention.
Keyphrases
- respiratory failure
- chronic obstructive pulmonary disease
- extracorporeal membrane oxygenation
- lung function
- mechanical ventilation
- clinical trial
- randomized controlled trial
- end stage renal disease
- acute respiratory distress syndrome
- healthcare
- intensive care unit
- chronic kidney disease
- ejection fraction
- newly diagnosed
- physical activity
- prognostic factors
- air pollution
- hepatitis b virus
- genome wide
- peritoneal dialysis
- liver failure
- gene expression
- combination therapy
- patient reported outcomes
- aortic dissection